Results

Total Results: 396 records

Showing results for "depression".
Users also searched for: guidelines

  1. www.qualitymeasures.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/co-nm-specialinnovation.html
    August 01, 2015 - health questions adapted from the Patient Health Questionnaire-2 (PHQ-2), a two-question screener for depression … School staff routinely used information on suspected depression from the eSHQ to trigger further assessment … in Colorado and nearly one in three in New Mexico seen at these SBHCs have one or more symptoms of depression … Improving recognition of adolescent depression in primary care.
  2. www.qualitymeasures.ahrq.gov/prevention/chronic-care/decision/mcc/mccpublications.html
    May 01, 2014 - The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control … Risk of coronary heart disease events over 15 years among older adults with depressive symptoms. … Association between chronic illness complexity and receipt of evidence-based depression care. … Racial/ethnic disparities, social support, and depression: examining a social determinant of mental health
  3. www.qualitymeasures.ahrq.gov/pqmp/publications/search.html?page=1
    March 24, 2018 - Hospital readmissions (6) Medical complexity (6) Primary care (6) Sickle cell anemia (6) Depression … measures, Primary care Parent Burden in Accessing Outpatient Psychiatric Services for Adolescent Depression … Parent Burden in Accessing Outpatient Psychiatric Services for Adolescent Depression in a Large State … Keywords: Behavioral health, Depression, Outpatient care Practice Style Variation in Medicaid
  4. www.qualitymeasures.ahrq.gov/questions/resources/diagnosis/step1.html
    November 01, 2020 - Avoid depression. Cope with your condition. Feel more in control of your situation.
  5. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/chipra-750-pennsylvania-state-snapshot.pdf
    January 01, 2018 - screening for developmental delays, autism, attention deficit hyperactivity disorder, adolescent depression … , and postpartum depression. … for pediatric conditions, providers indicated that sustaining electronic screening for postpartum depression
  6. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
    February 12, 2018 - vagal stimulus, β-blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression
  7. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
    April 26, 2018 - vagal stimulus, β- blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression
  8. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
    February 09, 2018 - vagal stimulus, β- blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression
  9. www.qualitymeasures.ahrq.gov/questions/resources/diagnosis/step2.html
    November 01, 2020 - Research on support groups shows that participants feel less anxious, experience less depression, have … Counselor or therapist A good counselor or therapist can help you cope with sadness, depression, and
  10. www.qualitymeasures.ahrq.gov/practiceimprovement/delivery-initiative/casalino/paper/idkeydsrapa.html
    February 01, 2014 - mental health and co-location systems of primary care and mental health care on outcomes including depression … treatment strategies (e.g., psychotherapy, antidepressants, combination treatment with case management) for depression
  11. www.qualitymeasures.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/supplhighlight13.html
    June 01, 2015 - 10–17 per collaborative, over four collaboratives 9–12 3–4 Asthma, immunizations, adolescent depression … ✓ NC 26 24 2-3 Learning collaborative model, community linkages and referrals, maternal depression
  12. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
    April 25, 2018 - vagal stimulus, β-blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression
  13. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/emotional-wellness-resources-electronic.docx
    March 01, 2022 - The test for depression, anxiety, and post-traumatic stress disorder, or PTSD, may be the most helpful
  14. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/emotional-wellness-resources-qr-codes.docx
    March 01, 2022 - The test for depression, anxiety, and post-traumatic stress disorder, or PTSD, may be the most helpful
  15. www.qualitymeasures.ahrq.gov/topics/d.html
    April 29, 2024 - D Data Data: Data Visualization Decision Making Dental and Oral Health Depression
  16. www.qualitymeasures.ahrq.gov/research/publications/search.html?page=6
    January 01, 2017 - Publication Number: 14-0034-1-EF Consumer Guide - Comparing Talk Therapy and other Depression … This guide compares talk therapy and other depression treatments with antidepressants.
  17. www.qualitymeasures.ahrq.gov/news/blog/ahrqviews/high-quality-behavioral-healthcare.html
    December 01, 2022 - elevated awareness of this need for behavioral health services, with climbing rates of anxiety and depression … Still, more prevalent diseases such as depression, anxiety disorders, and trauma-related conditions continue
  18. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/statesummaries/nm-statesum.pdf
    July 01, 2015 - then addressed other QI topics given high priority by the State—pediatric overweight and obesity, depression … using standardized behavioral health screeners to determine whether youth identified as at risk for depression
  19. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
    February 09, 2018 - vagal stimulus, β- blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression
  20. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 15, 2018 - vagal stimulus, β-blocker drugs, or congenital heart disease; or otherwise unexplained persistent depression

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: